The concentration of the soluble fragment of transferrin receptor in serum
is an important new hematological parameter. Clinical and laboratory studie
s have shown that this serum form of the receptor reflects the total body m
ass of cellular transferrin receptor, 80% of which is contained in the eryt
hroid marrow. The two disorders that result in an elevation in the serum tr
ansferrin receptor are anemias associated with enhanced erythropoiesis and
tissue iron deficiency. The concentration of soluble transferrin receptor p
rovides a useful quantitative measure of the erythroid marrow mass and ther
eby assists clinically in categorizing the type of anemia. The most importa
nt clinical use of the serum transferrin receptor is in determining the cau
se of iron deficient erythropoiesis (that is, identifying iron deficiency a
nemia whether it occurs alone or in the presence of the anemia of chronic d
isease). Present evidence supports the routine use of the serum transferrin
receptor in the clinical evaluation of anemic patients.